FdaApplication
BLA 103946
Identifiers
- fda_app_no: BLA103946
Properties
| Property | Value |
|---|---|
| applicant_name | Sanofi-Aventis U.S. LLC |
| application_type | BLA |
| approval_date | 2002-07-12 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ELITEK | RASBURICASE | 1.5MG | VIAL;INTRAVENOUS |
| ELITEK | — | 7.5MG | For Injection |
2 products